Podcast How the BMC Achieves Clinical-to-Commercial Quality Continuity Across Its Biologics CDMO Platform 2 April 2026
Manufacturing News FDA Warning Surge: Regulatory Violations #1 Reason for CDMO Disqualification 11 March 2026
Content FDA’s GLP-1 Crackdown: Regulators Are Turning Up the Heat on Manufacturing Quality 6 March 2026
Expert Insight Why FDA’s CRL wave isn’t a CMC crisis — and what biotechs should do instead 3 March 2026
Podcast How Takeda Drives Quality Excellence Across External Manufacturing Networks 12 September 2025